Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Cost of care for cancer in a health maintenance organization.

5 references·16 citing·31 second hop

FromToDepth

this work references cited by second hop

References

1996Cost-Effectiveness in Health and Medicine7,192 cited
1992Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.1,655 cited
1997Economic foundations of cost-effectiveness analysis767 cited
1995Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care344 cited
1995Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis332 cited

Cited by

2018Global treatment costs of breast cancer by stage: A systematic review175 cited
2008The burden of illness associated with hepatocellular carcinoma in the United States153 cited
2015Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States142 cited
2004Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer140 cited
2005The economic burden of lung cancer and the associated costs of treatment failure in the United States124 cited
2011Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003121 cited
2009The Costs of Treating Breast Cancer in the US119 cited
2002Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service Settings116 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2007

Costs of cancer care in the USA: a descriptive review

106 cited

2018Costs of cancer along the care continuum: What we can expect based on recent literature95 cited

2007Assessing the economic burden of breast cancer in a US managed care population94 cited

2008The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer86 cited

2000Cost of Care for Patients in Cancer Clinical Trials86 cited

2004The Economic Cost of Squamous Cell Cancer of the Head and Neck85 cited

2000The Cost of Health Conditions in a Health Maintenance Organization84 cited

2001Observation Interval for Evaluating the Costs of Surgical Interventions for Older Women With a New Diagnosis of Breast Cancer83 cited